A two-drug combination (zanzalintinib plus atezolizumab) improved survival for metastatic colon cancer patients who already ...

In a new study, colon cancer patients on these medications were more likely to make it to the 5-year survival mark than patients not on the drugs. In a new study, colon cancer patients who took GLP-1 ...

GLP-1s were linked to a lower death risk in colon cancer in a recent study. Image credit: ARMEND NIMANI/Getty Images “This means that, “in addition to lowering glucose [blood sugar] and weight, they ...

A 20-cent “wonder drug” may do more than manage blood sugar. Researchers are investigating whether a widely used diabetes medication could aid in the fight against colorectal cancer after the disease ...

“Aspirin is a drug that is readily available globally and extremely inexpensive compared to many modern cancer drugs, which is very positive,” says Anna Martling.

Aspirin reduces the risk of colon cancer recurrence after surgery, but only in patients with a specific genetic marker ...

Exercise may significantly reduce the risk of colon cancer returning in patients after treatment, a new study has found. Subscribe to read this story ad-free Get unlimited access to ad-free articles ...

In a new study, colon cancer patients who took GLP-1 medications saw an increase in 5-year survivorship compared with patients who didnt take GLP-1s. The increase in survivorship was greatest in ...